European Society for Pediatric Dermatology Poster Presentation: Pediatric Data from Phase 2a Trial of AB-101a for Mild-to-Moderate Atopic Dermatitis

Alphyn Logo 1

NEWS PROVIDED BY
Alphyn Biologics
May 4, 2023, 07:25 ET

CONTACTS

 

Corporate:
Neal Koller
nkoller@alphynbiologics.com
(410) 690-8687

 

Media:
Susan Thomas
susan@endpointcommunications.net
(619) 540-9195